# IBN — ICICI Bank · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** IBN  
**Sources:** 16  
**Published:** 2026-10-06  
**Canonical:** https://app.k3vl4r.com/research/deep-research-ibn-icici-bank-catalysts-narrative-risks-6329

---

## Snapshot (as of ~Oct 6, 2026)

IBN trades around **$27.75–$28.02**, with a market cap of roughly **$99.6–$101B** [[9]](https://clearank.com/stock/icici-bank-ibn/)[[10]](https://www.zacks.com/stock/research/IBN/price-target-stock-forecast)[[12]](https://wallstsmart.com/stock/ibn)[[14]](https://stockanalysis.com/stocks/ibn/). Trailing P/E is ~16.9–17.7x and forward P/E ~16.0–16.9x [[3]](https://www.marketbeat.com/stocks/NYSE/IBN/earnings/)[[11]](https://stockanalysis.com/stocks/ibn/forecast/)[[14]](https://stockanalysis.com/stocks/ibn/). Beta is low (~0.26) [[12]](https://wallstsmart.com/stock/ibn)[[14]](https://stockanalysis.com/stocks/ibn/). The company is India's second-largest private-sector universal bank, listed on the NYSE as ADR (IBN) and on Indian exchanges, led by MD/CEO Sandeep Bakhshi [[1]](https://www.marketbeat.com/earnings/reports/2026-10-17-icici-bank-limited-stock/)[[17]](https://en.wikipedia.org/wiki/ICICI_Bank).

## Upcoming scheduled events

The dominant near-term catalyst is the **board meeting / earnings on October 17, 2026**, which is well-confirmed across multiple sources:

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-ibn-icici-bank-catalysts-narrative-risks-6329 (free to sign up)._
